Published in Hepatitis Weekly, February 22nd, 1999
At present, treatment of HIV infection uses small inhibitory molecules that target HIV protease; however, the emergence of resistant HIV strains is increasingly problematic.
"To circumvent this, we report here a new 'Trojan horse' strategy to kill HIV infected cells by exploiting HIV protease," researcher A.M. Vocero-Akbani and colleagues wrote ("Killing HIV Infected Cells by Transduction with an HIV Protease-Activated Caspase-3 Protein," Nature Medicine, January...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.